載入中
NASDAQHealthcareMedical - Instruments & Supplies
最新資料
US$55.298
+US$0.928 · +1.71%
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
一般交易時段
US$55.298
+US$0.928 · +1.71%
盤中時間採用ET。市場資料可能有所延遲。
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
日內區間
目前US$55.298
52週區間
目前US$55.298
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
持有
估值
56
合理估值
情緒
59
多空交錯
風險
36
中等風險
動能
39
動能減弱
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
日內區間
目前US$55.298
52週區間
目前US$55.298
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 40.92億 USD | 38.95億 USD | 35.93億 USD | 33.08億 USD | 29.23億 USD |
| 銷貨成本 | 16.1億 USD | 13億 USD | 12.35億 USD | 11.69億 USD | 9.67億 USD |
| 毛利 | 24.83億 USD | 25.96億 USD | 23.58億 USD | 21.4億 USD | 19.56億 USD |
| 研究與開發 | 1.72億 USD | 1.55億 USD | 1.37億 USD | 1.1億 USD | 9270萬 USD |
| 銷售、一般及管理費用 | 16.28億 USD | 15.34億 USD | 15.01億 USD | 13.42億 USD | 12.11億 USD |
| 營業費用 | 18億 USD | 18.9億 USD | 18.25億 USD | 16.32億 USD | 14.5億 USD |
| 利息支出 | 1億 USD | 1.14億 USD | 1.05億 USD | 5730萬 USD | 2310萬 USD |
| 折舊和攤銷 | 4.23億 USD | 3.75億 USD | 3.68億 USD | 3.46億 USD | 3.09億 USD |
| 營業利益 | 6.83億 USD | 7.06億 USD | 5.33億 USD | 5.08億 USD | 5.06億 USD |
| 淨利 | 3.75億 USD | 3.92億 USD | 2.94億 USD | 3.86億 USD | 29.45億 USD |
公司資料更新於 2026年10月12日。
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
第三方分析師預期可能變動，並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T205.28億0.02%129.43兆 JPY0.09%¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI4.35億0.02%2.3兆 USD0.03%US$381.89-0.01%
Vanguard S&P 500 ETFVOO3.63億0.02%1.8兆 USD0.03%US$715.5-0.01%
Vanguard Morningstar Small-Cap ETFVB3.15億0.17%1853億 USD0.03%US$289.26-0.08%
Vanguard Morningstar Small-Cap Value ETFVBR2億0.29%682億 USD0.05%US$235.44+0.43%
Invesco S&P 500 Equal Weight ETFRSP1.68億0.17%977.83億 USD0.20%US$213.42+0.18%
iShares Core S&P 500 ETFIVV1.41億0.02%8964.4億 USD0.03%US$781.86-0.01%
State Street SPDR S&P 500 ETFSPY1.3億0.02%8172億 USD0.09%US$778.42-0.02%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRInvesco S&P 500 Equal Weight ETFRSPiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
